The global life science tools and reagents market is anticipated to increase by USD 48 billion till 2028 at an average annual growth of 7.2 percent as per the latest report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global life science tools and reagents market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the life science tools and reagents industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product type, application, and region. The global market for life science tools and reagents can be segmented by product type: life science tools, life science COVID-19 diagnostics products. Life science tools and reagents market is further segmented by application: animal models, bioinformatics, cell biology, epigenetics, genomics, imaging and microscopy, proteomics, stem cells, others. The genomics segment was the largest contributor to the global life science tools and reagents market in 2021. Based on region, the life science tools and reagents market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By product type:
– life science tools
– life science COVID-19 diagnostics products
By application:
– animal models
– bioinformatics
– cell biology
– epigenetics
– genomics
– imaging and microscopy
– proteomics
– stem cells
– others
By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The report also provides analysis of the key companies of the industry and their detailed company profiles including Abcam plc, Abnova Corp., Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., Bruker Corp., Carl Zeiss Inc., Charles River Laboratories Inc., Danaher Corp., GE Healthcare, GenOway S.A., Hitachi High-Tech Group, Illumina, Inc., JEOL Ltd., Labcorp Drug Development, Luminex Corporation, Merck KGaA (includes Sigma Aldrich), Novozymes Inc., Olympus Inc., Perkin Elmer Inc., Perkin Elmer Inc., Plus Therapeutics Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global life science tools and reagents market.
– To classify and forecast the global life science tools and reagents market based on product type, application, region.
– To identify drivers and challenges for the global life science tools and reagents market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global life science tools and reagents market.
– To identify and analyze the profile of leading players operating in the global life science tools and reagents market.
Why Choose This Report
– Gain a reliable outlook of the global life science tools and reagents market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 7.2% |
| Pages | 92 |
| Key Players | Abcam plc, Abnova Corp., Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corp., Bruker Corp., Carl Zeiss Inc., Charles River Laboratories Inc., Danaher Corp., GE Healthcare, GenOway S.A., Hitachi High-Tech Group, Illumina Inc., JEOL Ltd., Labcorp Drug Development, Luminex Corporation, Merck KGaA (includes Sigma Aldrich), Novozymes Inc., Olympus Inc., Perkin Elmer Inc., Perkin Elmer Inc., Plus Therapeutics Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation |
The global radiation dose management market is projected to expand at a CAGR of ~7.9 percent across the forecast period of 2023 – 2029, according to the latest edition of the Global Radiation Dose Management Market Report. Radiation dose management refers to the practice of optimizing and regulating the radiation…
Global NGS library preparation automation market by product (automated instruments, automated kits and consumables), by sequencing type (RNA sequencing, DNA sequencing), by application (research, diagnostics), by institutions (pharmaceutical, laboratories, others), by region (Asia-Pacific (ex. China), Europe, North America, China, RoW (Rest of World)), outlook & forecast, 2023-2029
Global biometrics market by technology (hand geometry, fingerprint, face, iris, vein, voice, others), by end user (BFSI, commercial and retail, government and law enforcement, healthcare, travel and immigration, others), by region (North America, Europe, Asia-Pacific, Rest of World (RoW)), outlook & forecast, 2023-2029
Please fill out our form and we will get back to you.